Blood pressure: what nobody tells you
Blood pressure is written as two numbers: the higher systolic (the push when your heart beats) over the lower diastolic (the pressure between beats), in millimetres of mercury (mmHg). A single clinic reading is the weakest way to judge it, because nerves can inflate it (white-coat) or a normal clinic number can hide a high one at home (masked). UK guidance now leans on home and ambulatory readings to diagnose hypertension, treats anything from a healthy diet and less salt to weight, exercise, alcohol and sleep as real levers, and starts medication based on your numbers plus your overall cardiovascular risk.
Key facts
- Around 30 percent of UK adults have high blood pressure, and roughly a third of those are undiagnosed, which on recent estimates is several million people walking around untreated.8
- Because clinic readings can mislead, NICE recommends confirming a diagnosis with ambulatory (ABPM) or home (HBPM) monitoring, where the thresholds are set 5 mmHg lower than in clinic.1
- How you sit matters: a randomised trial found an unsupported arm hanging at the side overstated systolic pressure by nearly 7 mmHg, and an arm resting on the lap by about 4 mmHg, versus a properly supported arm.6
- The DASH eating pattern lowered systolic pressure by 11.4 mmHg in people with hypertension in a controlled feeding trial, a fall comparable to a single blood pressure drug.3
What the two numbers mean
Each heartbeat ejects blood into your arteries and the pressure peaks: that peak is the systolic number, the first and higher figure. Between beats the heart relaxes and refills, and the pressure settles to a trough: that is the diastolic number, the second and lower one. A reading of 128/78 means a systolic of 128 mmHg over a diastolic of 78. Both matter, but in adults over about 50 the systolic figure is the stronger predictor of heart attack and stroke, partly because arteries stiffen with age and the systolic number climbs while the diastolic often falls.
Blood pressure is not one fixed value. It rises when you talk, stand, feel stressed, drink coffee or carry a full bladder, and it dips in sleep. That natural variability is exactly why a single number, caught on one anxious morning in a clinic, is a poor basis for a label that may mean lifelong treatment. The question is never just "what is my blood pressure" but "what is my usual blood pressure, measured well".
Why home and ambulatory beat one-off clinic checks
Two well-described phenomena explain why context changes the reading. In the white-coat effect, blood pressure is genuinely raised in the clinic but normal away from it; NICE defines this as a discrepancy of more than 20/10 mmHg between clinic and average daytime out-of-clinic readings.1 In masked hypertension the reverse happens: the clinic number looks fine, under 140/90, while readings are high at home or on a 24-hour monitor. Masked hypertension is the more dangerous of the two precisely because it goes unnoticed.
This is not a minor footnote. A meta-analysis of initially untreated people found that, compared with true normal blood pressure, masked hypertension carried roughly the cardiovascular risk of sustained hypertension (adjusted hazard ratio about 2.1), whereas white-coat hypertension carried little excess risk in that analysis (hazard ratio near 1.0).2 Treat the wrong picture and you either medicate someone who does not need it or, worse, reassure someone who is quietly at risk.
Ambulatory monitoring (a cuff that takes readings automatically through the day and night) is the reference standard, because it captures dozens of measurements in real life, including during sleep, when a healthy pressure should dip. Home monitoring, done correctly over several days, is the practical alternative and the one the NHS actively supports. Both strip out the clinic-room artefact and give a truer average.
Evidence strength: that out-of-clinic readings predict cardiovascular outcomes better than clinic readings is supported by large prospective cohorts and is now embedded in UK, European and US guidelines. NICE recommends ABPM (or HBPM if ABPM is not tolerated) to confirm a diagnosis whenever clinic pressure sits between 140/90 and 180/120 mmHg.1
How to measure it properly
A home monitor is only as good as your technique, and small errors stack up fast. Use a validated upper-arm cuff (the British and Irish Hypertension Society publishes a list of validated devices); wrist and finger gadgets are less reliable. Get the cuff size right, because a cuff that is too small reads falsely high. Then control the position. The ARMS crossover trial randomised the order of three arm positions and found that, against an arm supported at heart height on a desk, resting the arm on the lap added about 4 mmHg to the systolic reading and letting it hang unsupported added nearly 7 mmHg.6 A 7 mmHg artefact is enough to turn a normal reading into a diagnosis.
For a reliable home reading, follow the same protocol NICE uses for diagnosis:
- Sit quietly for 5 minutes first, back supported, feet flat on the floor, legs uncrossed, in a calm room.
- Rest the bare upper arm on a table so the cuff is level with your heart. Do not talk during the reading.
- Avoid caffeine, smoking and exercise for 30 minutes beforehand, and empty your bladder.
- Take two readings a minute apart, morning and evening, for at least 4 days and ideally 7. Discard day one, then average the rest.1
One high reading is not a diagnosis and not an emergency. What counts is the pattern across many well-taken measurements.
UK thresholds and targets
NICE guideline NG136 sets the UK framework, and its central trick is that out-of-clinic thresholds are 5 mmHg lower than clinic ones, because away from the white-coat effect the same risk shows up at a slightly lower number.1 Diagnosis is confirmed when the clinic pressure is 140/90 or higher and the ABPM daytime average or HBPM average is 135/85 or higher. The stages, and the matched home and ambulatory figures, are set out below.
| Category | Clinic reading | Home or ambulatory average |
|---|---|---|
| Stage 1 hypertension | 140/90 to 159/99 | 135/85 to 149/94 |
| Stage 2 hypertension | 160/100 up to 180/120 | 150/95 or higher |
| Stage 3 (severe) | 180 systolic or higher, or 120 diastolic or higher | Same-day clinical assessment |
The treatment targets follow the same logic. For adults under 80 on treatment, NICE aims for a clinic pressure below 140/90, which corresponds to a home or ambulatory average below 135/85. For adults aged 80 and over, the clinic target is below 150/90, or below 145/85 on home or ambulatory monitoring.1 The age allowance reflects honest uncertainty about pushing very elderly or frail people too low. People with chronic kidney disease and significant protein in the urine, or with diabetes and kidney involvement, are often treated to a tighter target, which is why these numbers are a starting point for a conversation, not a self-diagnosis. Our health library covers how to read an "in range" result that may still not be right for you.
The lifestyle levers that actually work
Lifestyle is not a consolation prize before the "real" treatment. Several measures produce blood pressure falls in the same league as a starting dose of medication, and they stack.
Sodium and potassium
Cutting salt lowers blood pressure, and the effect is dose-dependent. In the landmark DASH-Sodium feeding trial, moving from a high to a low sodium intake on a control diet dropped systolic pressure by around 6 to 7 mmHg, with the largest falls in those who started highest.4 The other half of the equation is potassium, which counteracts sodium. The Salt Substitute and Stroke Study (SSaSS), an open-label trial of 20,995 people across 600 villages in rural China, replaced ordinary salt (100 percent sodium chloride) with a substitute of 75 percent sodium chloride and 25 percent potassium chloride. Over about five years the substitute group had 14 percent fewer strokes, 13 percent fewer major cardiovascular events and 12 percent fewer deaths.5
Potassium-based salt substitutes are not safe for everyone. NICE specifically advises against them in older people, people with diabetes, kidney disease or pregnancy, and anyone taking ACE inhibitors, angiotensin receptor blockers or potassium-sparing diuretics, because of the risk of dangerously high potassium.1 For these groups, reduce salt rather than substitute it, and do not take potassium supplements for blood pressure: NICE recommends against that too.
The DASH eating pattern
DASH (Dietary Approaches to Stop Hypertension) is the most rigorously tested diet for blood pressure: rich in vegetables, fruit, wholegrains, beans, nuts and low-fat dairy, and low in red and processed meat, sugary food and saturated fat. In the original controlled feeding trial led by Lawrence Appel, the full DASH pattern lowered systolic pressure by 11.4 mmHg and diastolic by 5.5 mmHg in people who already had hypertension, compared with a typical control diet, within weeks.3 Because food was supplied in that trial, real-world effects are usually smaller, but the direction and the mechanism are solid.
Weight, exercise, alcohol and sleep
These are the levers most people underrate:
- Weight. A meta-analysis of 25 randomised trials found blood pressure fell by roughly 1 mmHg systolic for every kilogram lost (about 1.05/0.92 mmHg per kg).9 Losing 5 kg is a meaningful drop.
- Exercise. A meta-analysis of aerobic-exercise trials found average reductions of about 3.8 mmHg systolic and 2.6 mmHg diastolic, in people with and without hypertension alike.10 Regular brisk walking counts.
- Alcohol. A meta-analysis of 36 trials found that cutting back lowered blood pressure mainly in those drinking more than two drinks a day, with bigger falls the heavier the baseline intake.7 For heavier drinkers this is one of the most effective single changes.
- Sleep. Short or disrupted sleep raises blood pressure, and obstructive sleep apnoea is a common, treatable cause of stubborn (resistant) hypertension. Treating apnoea with CPAP lowers blood pressure modestly on average (a few mmHg), with larger falls in people whose hypertension is resistant to drugs.11
Stress and relaxation are harder to pin down. Chronic stress plausibly nudges blood pressure up, but the evidence for relaxation therapies as a treatment is weak enough that NICE removed its earlier recommendation on them.1 That does not mean stress is irrelevant, only that the measurable wins sit with diet, weight, movement, alcohol and sleep. If you want to organise these changes into a coherent plan, our stack builder can help you sequence them, and our wider insights put the mechanisms in context.
When medication is warranted
Medication is not decided by your blood pressure number alone, but by that number combined with your overall cardiovascular risk. Under NG136, NICE offers drug treatment to adults of any age with persistent stage 2 hypertension. For stage 1 in people under 80, it recommends discussing treatment when there is also target-organ damage, established cardiovascular disease, kidney disease, diabetes, or an estimated 10-year cardiovascular risk of 10 percent or more (calculated with a tool such as QRISK).1 Lifestyle advice continues whether or not you start a drug.
That the benefit is real is not in doubt. The SPRINT trial randomised 9,361 higher-risk adults to a systolic target below 120 versus below 140 mmHg; the intensive arm cut major cardiovascular events by about 25 percent and all-cause death by about 27 percent, enough that the trial was stopped early.12 SPRINT used a particular measurement method and excluded people with diabetes or prior stroke, so its exact target is not transplanted wholesale into UK practice, but it settled the bigger argument: lowering raised blood pressure prevents events and saves lives.
If you already take blood pressure medication, do not stop or change the dose on your own, even if home readings look good or you feel fine. Blood pressure usually has no symptoms, and stopping treatment can let it climb silently. Any change should be made with your GP, who can adjust treatment against your readings safely.
- Could we confirm my diagnosis with home or ambulatory monitoring rather than relying on clinic readings?
- Given my numbers, could this be white-coat or masked hypertension?
- What is my QRISK score, and does it change whether I should start medication for a stage 1 reading?
- What home or ambulatory target should I aim for, given my age and any kidney or diabetes history?
- Is a potassium-based salt substitute safe for me, or should I just reduce salt?
References
- NICE guideline NG136. Hypertension in adults: diagnosis and management. Published 2019, last updated 2026. nice.org.uk.
- Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25(11):2193-2198. Related meta-analysis, PMID 20847724.
- Appel LJ, Moore TJ, Obarzanek E, et al. A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure (DASH). N Engl J Med. 1997;336(16):1117-1124. nejm.org.
- Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on Blood Pressure of Reduced Dietary Sodium and the DASH Diet (DASH-Sodium). N Engl J Med. 2001;344(1):3-10. nejm.org.
- Neal B, Wu Y, Feng X, et al. Effect of Salt Substitution on Cardiovascular Events and Death (SSaSS). N Engl J Med. 2021;385(12):1067-1077. nejm.org.
- Liu H, Zhao D, Sabit A, et al. Arm Position and Blood Pressure Readings: The ARMS Crossover Randomized Clinical Trial. JAMA Intern Med. 2024;184(12):1436-1442. jamanetwork.com.
- Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2(2):e108-e120. thelancet.com.
- NHS Digital. Health Survey for England: adults' health (hypertension prevalence and undiagnosed rates). digital.nhs.uk.
- Neter JE, Stam BE, Kok FJ, et al. Influence of Weight Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials. Hypertension. 2003;42(5):878-884. ahajournals.org.
- Whelton SP, Chin A, Xin X, He J. Effect of Aerobic Exercise on Blood Pressure: A Meta-Analysis of Randomized, Controlled Trials. Ann Intern Med. 2002;136(7):493-503. acpjournals.org.
- Pedrosa RP, Drager LF, et al. Effects of OSA treatment with CPAP on blood pressure in resistant hypertension. Am J Respir Crit Care Med / related trials. PMC3927443.
- SPRINT Research Group. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015;373(22):2103-2116. nejm.org.
Nine free tools on this site help you act on what you just read: keep a think-out-loud health journal, prepare a GP appointment, check a supplement stack before buying more, or decode blood results.
Symptom Decoder · Health Journal · GP Script Generator · Stack Risk Checker · Lab Result Primer · Health MOT · All tools. Want it all synced and organised in one private map? The Club, £10/month.
This article is educational and does not constitute medical advice, diagnosis, or a treatment recommendation. Medication uses described as “off-label” are not licensed for that purpose in the UK and should only be considered under qualified clinical supervision. Always speak to your GP, pharmacist, or a registered specialist before starting, stopping, or changing any treatment. If you have severe or alarm symptoms - unintentional weight loss, blood in your stool, difficulty swallowing, persistent vomiting, a fever, or severe pain - seek urgent medical care.